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Abstract: Acoustic resolution photoacoustic Doppler velocimetry promises 
to overcome the spatial resolution and depth penetration limitations of 
current blood flow measuring methods. Despite successful implementation 
using blood-mimicking fluids, measurements in blood have proved 
challenging, thus preventing in vivo application. A common explanation for 
this difficulty is that whole blood is insufficiently heterogeneous relative to 
detector frequencies of tens of MHz compatible with deep tissue 
photoacoustic measurements. Through rigorous experimental measurements 
we provide new insight that refutes this assertion. We show for the first time 
that, by careful choice of the detector frequency and field-of-view, and by 
employing novel signal processing methods, it is possible to make velocity 
measurements in whole blood using transducers with frequencies in the tens 
of MHz range. These findings have important implications for the prospects 
of making deep tissue measurements of blood flow relevant to the study of 
microcirculatory abnormalities associated with cancer, diabetes, 
atherosclerosis and other conditions. 
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1. Introduction 
Photoacoustic flowmetry (PAF) is an emerging technique that offers significant advantages 
compared to existing methods for measuring blood velocity. The general principle of PAF 
involves illuminating red blood cells (RBCs) with modulated laser light in order to generate 
ultrasound (photoacoustic) waves; the motion of the RBCs is then monitored via changes such 
as time, phase or frequency shifts in the photoacoustic waves they emit. Unlike Doppler 
ultrasound [1] photoacoustic methods are well suited to measuring the low flow velocities in 
microvessels. This is a result of the high optical absorption difference between blood and the 
surrounding tissue, which enables superior blood vessel contrast; in Doppler ultrasound the 
small signal backscattered from microvessels is difficult to distinguish from the surrounding 
tissue which may also be moving at comparable speeds due to respiratory and cardiac motion. 
In addition, when using diffuse illumination, PAF has several advantages over purely optical 
techniques. It can provide greater penetration depth than optical methods such as flow 
cytometry [2], confocal microscopy [3] and optical coherence tomography [4,5] that use 
ballistic photons and are therefore limited to depths of less than 1 millimetre due to optical 
scattering. Deeper penetration is possible using optical techniques such as laser Doppler 
velocimetry [6] that employ diffuse light rather than ballistic photons but resolution is 
relatively poor. By contrast PAF can provide better spatial resolution on account of the 
weaker scattering of acoustic waves compared to light. 
Various photoacoustic flowmetry methods have been developed and successfully validated 
using blood flow phantoms [7–12]. However, in vivo velocity measurements [13–18] have so 
far only been achieved by focussing the laser light in the tissue. This so-called “optical 
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resolution” (OR) mode is limited to a maximum penetration depth of less than approximately 
1 mm due to strong optical scattering in tissue, and thus fails to exploit the intrinsic potential 
of photoacoustic velocimetry for deeper tissue measurements. The “acoustic resolution” (AR) 
mode employs wide-field diffuse illumination and the signal is localised by defining the 
region from which the photoacoustic waves are received by using a focussed ultrasound 
detector or array. The use of diffuse illumination opens up the possibility for several 
centimetres of tissue penetration, but the successful implementation of AR-PAF remains a 
challenge. 
Previous work [19,20] has demonstrated the underlying physical principles of AR-PAF 
using blood-mimicking phantoms comprising micron scale absorber suspensions, but only at 
concentrations an order of magnitude lower than a physiologically realistic RBC haematocrit. 
For higher concentrations it has proved very challenging to make accurate velocity 
measurements [19]. Perhaps unsurprisingly therefore AR-PAF measurements in whole blood 
in vivo have not been reported either. A common explanation for this difficulty is that whole 
blood is insufficiently optically heterogeneous to permit accurate AR-PAF measurements 
using detector frequencies consistent with mm-cm scale penetration depths in tissue (i.e. 
frequencies in the MHz to tens of MHz range). Optical heterogeneity is a crucial requirement 
for the detection of flow using AR-PAF as without it moving blood resembles a continuum 
that is photoacoustically indistinguishable from static blood. To perceive heterogeneity 
requires an ultrasound detector able to resolve the “granularity” of blood; however, a simple 
consideration of the spatial scale of the distribution of RBCs in whole blood suggests that 
adequate resolution would only be provided by detector frequencies well beyond the tens of 
MHz range. Through experimental AR-PAF measurements in whole blood we provide new 
insight and evidence that refutes this assertion. 
This study shows for the first time that, by careful choice of the detector bandwidth and 
field-of-view, and by employing novel signal processing methods, it is possible to make AR-
PAF measurements in whole blood using detectors with frequencies in the tens of MHz range. 
The requirement for heterogeneity in the blood is investigated using detectors with different 
centre frequencies, and also different degrees of RBC heterogeneity. In addition, different 
wavelengths of light and a range-gating analysis are employed to validate and address the 
light penetration problem identified in previous work [19]. These findings have significant 
implications for the prospects of making deep tissue measurements of blood flow relevant to 
the study of microcirculatory abnormalities associated with vascular diseases [21], cancer [22] 
and other conditions. 
2. Time correlation acoustic resolution photoacoustic Doppler velocimetry 
The principles of acoustic resolution photoacoustic Doppler velocimetry are described in 
detail in references [7,19,23], and the concept is illustrated in Fig. 1. Briefly, wide-field 
illumination of the tissue using a pair of laser pulses separated by a time T produce a 
corresponding pair of photoacoustic waves emitted by RBCs flowing in a subsurface vessel. 
Upon detection at the surface, these waves gives rise to a pair of photoacoustic waveforms 
that are identical but time shifted with respect to each other due to the motion of the RBCs. 
The time shift ts is estimated by cross-correlation of the two waveforms and used to calculate 
the RBC velocity V’: 
 
cosθ
sctV'
T
=  (1) 
where c is the sound speed, and θ is the angle between the transducer axis and the flow 
direction. As illustrated in Fig. 1, the measurement is localised by selecting an appropriate 
time-window of each waveform in a manner analogous to range-gating in conventional pulsed 
wave Doppler ultrasound. So, for example, with reference to Fig. 1, p1(t) and p2(t) of the 
detected waveforms are segments that correspond to the location of the vessel at a distance F 
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along the transducer axis and the length D of these segments defines the axial spatial 
resolution. If D is larger than the blood vessel diameter projected along the transducer axis, 
the measurement is integrated over the vessel cross section and the estimated time shift ts 
yields the average velocity of the RBCs. Time-windowing to select a smaller segment of the 
signals, giving for example p1,seg(t) and p2,seg(t), enables estimation of the velocity at a specific 
range-gate location along the transducer axis within the vessel. In each case the time shifts are 
estimated by calculating the cross-correlation between the corresponding signal segments 
[7,19]. 
 
Fig. 1. Schematic illustrating the principle of time correlation AR-PAF. The two signals are 
generated from clusters of moving red blood cells (RBCs) when illuminated by a pair of laser 
pulses separated by a time T. The inset shows the distribution of RBCs (represented by solid 
ellipses) when the first laser pulse is fired, and the new positions (unfilled ellipses) coincident 
with the firing of the second laser pulse a time T later. Between the two pulses the RBCs have 
moved from A to B, a distance l along the blood vessel. The waveforms show sections of the 
two photoacoustic signals p1(t) and p2(t) that correspond to the location of the blood vessel and 
illustrate the time shift ts between the two due to the motion of the RBCs along the vessel. It is 
also possible to calculate the velocity in specific regions of the vessel by time-windowing to 
select appropriate signal segments such as p1,seg(t) and p2,seg(t) in a manner analagous to range-
gating in Doppler ultrasound. 
3. Experimental design 
Figure 2 shows the experimental setup used to acquire photoacoustic blood velocity 
measurements using excitation wavelengths in the range 450 nm to 680 nm. In principle, the 
measurements could be achieved by using a single laser source to generate a pair of laser 
pulses. However, in the absence of a wavelength-tuneable laser system capable of providing 
nanosecond laser pulses with the required sub-millisecond pulse separations, two OPO laser 
systems (Innolas Spitlight 600 and Newport Spectra-Physics Quanta-Ray / GWU GmbH 
VisIR) were used. The two laser systems were sequentially triggered via a pulse delay 
generator which was set to deliver an appropriate time delay (T = 0.5 ms) between successive 
laser pulses in a pair. The output of both lasers were coupled into 1.5 mm diameter multimode 
optical fibres positioned so as to illuminate the same area (approximately 1 cm2, with a 
fluence < 10 mJ/cm2) of the polymer tube (diameter approximately 0.4 mm) containing 
flowing RBCs. The photoacoustic signals were detected using one of the six focussed 
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ultrasound detectors listed in Table 1. The signals were amplified and captured by an 
oscilloscope, and then downloaded to a PC, where they were processed to calculate the time 
shift ts that arises due to motion of the RBCs. The diameter of the illuminated region was at 
least 5 mm and thus much larger than the lateral dimensions of the detector focus in order to 
be representative of the acoustic resolution mode of photoacoustic detection. 
Velocity measurements were made for various blood samples at different concentrations 
expressed as a percentage of the undiluted sample, which had a physiologically representative 
concentration. A typical concentration for the 100% (undiluted) case was 5 x 109 RBCs per ml 
(haematocrit: 0.56; haemoglobin concentration: 155 g/l) but this varied between subjects; the 
specific measured concentrations are therefore stated in the figures for each result in section 4. 
For the measurements shown in section 4.3, the RBCs were sourced from whole human blood 
at a normal physiological concentration and diluted to 25% and 12.5% using phosphate 
buffered saline (PBS). The samples were refrigerated when not in use, and all experiments 
were conducted within nine days of obtaining the fresh sample from the human volunteer. In 
order to produce the range of haematocrits shown in Fig. 5 the human blood samples were 
first washed with PBS and then diluted to concentrations ranging from 3% to 80%, and the 
haematocrits verified in each case (Sysmex XE-5000 Automated Hematology System). For 
the measurements shown in Fig. 3 the erythrocytes (red blood cells, RBCs) were obtained 
from the UCLH Blood Transfusion Unit in additive solution, with the leucocytes (white blood 
cells) depleted. Phosphate buffered saline was added to give a concentration of RBCs 
equivalent to approximately 5% of a normal haematocrit. 
To obtain a single velocity estimate, the tube was irradiated by a series of 25 laser pulse 
pairs. The pulses within each pair were separated by T = 0.5 ms, which was identified as 
optimal for the range of velocities investigated. Measurements V’ ± ΔV’/2 were made for 
average flow speeds |V| in the range 0 to 80 mm/s. The syringe pump could be programmed to 
deliver flow rates in steps of 0.01 ml/hr, and the pre-selected rate and the inner diameter of the 
tube were used to calculate |V| in mm/s. Uncertainties ΔV were based on the 5% tolerance in 
the diameter of the tubing. These “known” values and uncertainties correspond to the average 
flow velocity V ± ΔV/2 and were compared with the measured V’ ± ΔV’/2 acquired via cross-
correlation of the photoacoustic waveform pairs, as described in references [7,19]. The 
average flow velocity was calculated by cross-correlating the entire 5000-point (1.25 µs) time 
series of the signals, or by applying the range-gating method which involved evaluating signal 
segments in 250-point (62.5 ns) time windows, as described in reference [19] and in the 
previous section. 
Table 1. Spherically focussed transducers used variously to detect photoacoustic signals 
generated in red blood cellsa 
Centre 
frequency, f0 
−6 dB 
bandwidtha 
Transducer 
materialb 
Focal 
length 
FWHM beam 
widthc 
Axial 
resolutiona 
MHz MHz  mm mm mm 
5  2  PZT  64  0.97*  0.60 
15 8 PZT 19 0.15 0.20 
20 11 PZT 19 0.33* 0.15 
30 23 PZT 19 0.35* 0.06 
50 40 PZT 51 0.24 0.04 
25 25 PVDF 24 0.24 0.07 
aEstimated from the manufacturers’ specifications.bThe PZT transducers were manufactured by Panametrics Olympus 
NDT Inc. (Waltham, Massachusetts, USA), and the 25 MHz transducer was made by Precision Acoustics Ltd. 
(Dorchester, UK).cValues of the full-width-half-maximum (FWHM) at the transducer focus: the FWHM values 
marked * were measured by mapping the transmitted transducer beam profiles using a Fabry-Perot sensor [24]; the 
other FWHM values are calculated from the transducer characteristics using Eq. (9) in ref [25]. 
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 Fig. 2. Experimental setup for pulsed photoacoustic Doppler blood flow measurements. Laser 
pulses separated by a time T are used to generate pairs of photoacoustic waveforms which are 
detected by an ultrasound receiver positioned at an angle θ to the flow axis. This angle was 
measured to the nearest degree using a turntable with angular markings at 1° intervals, and 
verified by horizontally translating the tube and comparing the measured distances with those 
calculated from cross-correlation of photoacoustic signals acquired before and after translation. 
The inset shows that whilst a large area (at least 5 mm diameter) of the red blood cells (RBCs) 
is illuminated, photoacoustic signals are collected from a smaller region defined by the 
transducer focal spot in order to be representative of the acoustic resolution mode of 
photoacoustic detection. 
4. Results: blood velocity measurements 
Previous work [19] has demonstrated the feasibility of making velocity measurements in a 
blood mimicking phantom comprising an aqueous suspension of 3 µm polystyrene 
microspheres using time correlation AR-PAF. However, it was observed that for 
concentrations approaching physiologically realistic levels, the measurement accuracy and 
resolution were poor. Indeed at the highest concentrations used it was impossible even to 
detect flow. Two factors were identified as being responsible for these limitations. The first 
relates to the requirement for sufficient absorber heterogeneity as perceived by the detector. 
At high concentrations, the finite bandwidth of the detector and its lateral field-of-view (FOV) 
can result in the absorber distribution being perceived as optically homogenous thereby 
precluding the detection of flow. The second factor relates to the extent to which light can 
penetrate into the vessel. Insufficient light penetration can lead to measurements that are 
biased towards the slower velocities at the edge of the vessel resulting in under-reading of the 
average flow velocity. In the following sections, both factors are explored using blood as the 
absorber, rather than the absorbing microspheres used previously [19]. Sections 4.1 and 4.2 
describe the influence of the detector characteristics in the context of absorber heterogeneity 
and their impact on velocity measurement accuracy. The results in Section 4.3 illustrate how 
velocity measurement accuracy varies for different RBC concentrations, and using different 
wavelengths of light in order to vary the light penetration. 
4.1 Absorber heterogeneity: photoacoustic signal bandwidth and the influence of the detector 
characteristics 
The critical challenge in terms of making accurate AR-PAF measurements in whole blood 
relates to the spatial scale of the distribution of the RBCs within the plasma relative to the 
minimum detectable acoustic wavelength. More generally, this is referred to as the degree of 
absorber “heterogeneity”. Some level of spatial heterogeneity in the absorption distribution is 
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essential. This is because time-correlation AR-PAF relies upon tracking the motion of a 
cluster of RBCs by measuring time shifts in the photoacoustic signals emitted by the cluster 
when irradiated by a pair of laser pulses. If the RBCs are so tightly packed as to approximate 
an optically homogeneous medium, the photoacoustic waveforms produced by successive 
laser pulses will be temporally identical. There is therefore no detectable time shift and the 
motion is indistinguishable from the static case. “Heterogeneity” in this context is very much 
a relative term. It depends critically on the ability of the detector to resolve the “granularity” 
of the absorber distribution. This resolving ability is a function of both the intrinsic bandwidth 
of the detector and its lateral field-of-view as discussed below. 
4.1.1 Intrinsic detector centre frequency and bandwidth 
Absorber heterogeneity depends most obviously on the detector centre frequency and 
bandwidth. An ensemble of microscopic absorbers that is perceived as heterogeneous using a 
broadband high frequency detector may appear homogenous to a lower frequency detector 
and preclude the detection of flow. In order to illustrate this notion of perceived heterogeneity, 
velocity measurements of a RBC suspension flowing in a 390 µm tube were made using the 
six different transducers in Table 1. In these experiments, a relatively low concentration of 
RBCs was used (haematocrit Ht = 0.023, approximately 5% of a physiologically normal 
haematocrit) for illustrative purposes. Figure 3 shows the accuracy obtained for the different 
transducers, plotted as the mean fractional error between the known V and measured V’ 
average velocities for all N measurements made across the velocity range: 
 ( )Mean fractional erro 1              0r = V V' VVN V
−  ≠     (2) 
It is evident that accuracy decreases significantly as the detector centre frequency is reduced 
and renders the suspension increasingly homogeneous. Reducing the detector frequency 
further, below the lowest frequency detector used here (5 MHz), would reduce accuracy to the 
extent that even the detection of flow would be impossible. Note that, as discussed in section 
4.1.2 below, the signal can also be bandlimited by the detector lateral field-of-view (the 
FWHM beamwidth in Table 1). Since the field-of-view (FOV) increases with decreasing 
frequency for some of the transducers in Fig. 3, this could also be responsible for the 
reduction in accuracy. However, this increase in FOV is modest (except for f0 = 5 MHz) and 
for some of the transducers the FOV actually reduces as the frequency decreases (e.g. f0 = 15 
MHz and f0 = 25 MHz) yet the general trend of decreasing accuracy with decreasing 
frequency remains. This suggests that for the low concentration (5%) used in this example the 
FOV is not significantly bandlimiting the signal. As discussed in the following section, it is 
only at higher concentrations that bandlimiting due to the FOV is observed. 
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 Fig. 3. Comparison of the accuracy of velocity measurements made using transducers with 
centre frequencies ranging from 5 MHz to 50 MHz (see Table 1). For each transducer the 
measurements were made for red blood cells (5% of a normal physiological haematocrit) 
flowing in a 390 μm tube, and illuminated with 532 nm laser pulses separated by T = 0.5 ms. 
The accuracies are the fractional errors of measurements V’ made for known velocities V < 50 
mm/s. The error bars represent the standard error on the mean fractional error. 
4.1.2 Detector field-of-view (FOV) 
The deleterious effect of reducing the intrinsic detector centre frequency and bandwidth on 
accuracy, as illustrated in Fig. 3, is perhaps unsurprising. However, as described in reference 
[19], there is an additional less obvious detector characteristic, namely, its lateral field-of-
view (FOV), that can similarly bandlimit the signal and compromise accuracy. To illustrate 
this, consider the photoacoustic signal produced by a random distribution of microscopic 
absorbers and recorded by a focussed detector of unlimited bandwidth and a lateral FOV 
defined by the diameter of its focal spot as illustrated in Fig. 4. The detected time-resolved 
photoacoustic signal represents a series of time-retarded projections of the initial pressure 
distribution p0 integrated over successive cross sectional surfaces at increasing depths within 
the focal region. At low concentrations, the absorbers are relatively sparsely distributed. The 
mean value of p0 from one cross sectional surface to the next therefore fluctuates significantly 
resulting in a corresponding rapid time-varying fluctuation in the detected PA waveform. This 
fine “structure” in the PA waveform is characteristic of a heterogeneous suspension and 
permits accurate velocity measurements to be made. As the concentration increases however, 
the fluctuations in the mean value of p0 gradually reduce and the structure in the PA waveform 
is smoothed out. The absorber distribution is then perceived as being less heterogeneous 
resulting in reduced measurement accuracy. Eventually, when the concentration is sufficiently 
high, the fine structure in the signal is lost altogether. The PA waveform is then no longer 
characteristic of the micron scale RBC spatial distribution but corresponds to that of a 
relatively large cylinder of uniform absorption. Under these conditions, the suspension is 
perceived as wholly homogeneous precluding even the detection of flow. A detector with a 
large focal spot will result in perceived homogeneity occurring at a lower concentration than a 
more tightly focussed detector as the former will integrate over a greater number of absorbers 
and thus smooth out the mean p0 fluctuations to a greater extent. 
In the frequency domain, the above-mentioned spatial averaging effect is manifested by a 
downshift in the acoustic frequency spectrum: as the absorber concentration is increased, the 
high frequencies are suppressed whilst the low frequency content is enhanced. Note that, 
although the signal is bandlimited by this type of spatial averaging, it is subtly different from 
the bandlimiting effect imposed by the intrinsic frequency response characteristic of the 
detector described in section 4.1.1. In the latter case, the signal is simply low pass filtered and 
the energy of the signal reduced. By contrast, spatial averaging due to the detector lateral FOV 
produces a re-weighting or downshifting of the acoustic spectrum to lower frequencies but the 
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total signal energy is not reduced. However, in the context of absorber heterogeneity the 
consequences are identical in that the higher frequencies are lost and the absorber suspension 
is perceived as being more homogenous thus compromising measurement accuracy. 
 
Fig. 4. Illustration of bandlimiting due to spatial averaging over the detector field-of-view. At 
low concentrations, the absorbers within the tube are relatively sparsely distributed; there are 
rapid time-varying fluctuations in the detected photoacoustic (PA) waveform, and the acoustic 
frequency spectrum is broad. This permits accurate velocity measurements to be made. At high 
concentrations, the fluctuations in the PA waveform are smoothed out and the frequency 
spectrum is downshifted; the absorber distribution is perceived to be less heterogeneous and 
thus it is difficult to track the absorber motion and accurately measure the flow velocity. 
The bandlimiting effect of spatial averaging on the acoustic frequency spectrum can be 
observed in Fig. 5, which shows the frequency content of signals acquired for a high RBC 
concentration (100% of a physiologically normal RBC haematocrit Ht = 0.41) and a low RBC 
concentration (Ht = 0.01, which is approximately 3% of a physiologically realistic 
concentration) obtained using the 30 MHz focussed transducer (Table 1). For the 3% 
concentration, there is significant frequency content extending to approximately 50 MHz. For 
the 100% concentration, the high frequency components of the signal are significantly 
reduced compared to the 3% suspension with negligible frequency content beyond 30 MHz. 
To illustrate this downshifting behaviour more comprehensively, the weighted mean 
frequency (WMF) was calculated from photoacoustic spectra (comprised of i discrete 
frequency values fi each with normalised amplitude ai) obtained using samples of 12 different 
RBC haematocrits: 
 Weighted mean frequency i ii
ii
a f
a
=

   (3) 
These data are displayed in Fig. 5(b). It shows the mean frequency progressively 
decreasing as the RBC concentration increases and for haematocrits greater than about 0.2, the 
mean frequency remains constant at around 17 MHz. This is broadly in agreement with the 
results shown previously for a microsphere blood phantom [19] where the mean frequency 
also dropped progressively with increasing absorber concentration before reaching a plateau. 
The relatively low mean frequencies observed in Fig. 5(b) are perhaps surprising. Intuition 
based on the micron spatial scale of RBC suspensions and previous simulation studies [26,27] 
suggest that the frequency spectra of PA signals generated in blood should extend well 
beyond 100 MHz. However, these simulations either neglect the effect of the detector FOV or 
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simulate the photoacoustic spectrum of a single RBC in which case spatial averaging is not 
relevant. The much lower frequencies observed in Fig. 5 are a direct consequence of the 
relatively large FOV (FWHM spot size ~350 µm) of the focused transducer used. This results 
in significant spatial averaging to the extent that it bandlimits the signal to well below the 
intrinsic bandwidth of both the PA source (the RBC suspension) and the detector. 
 
Fig. 5. Frequency downshifting due to spatial averaging arising from the detector FOV. (a) 
Comparison of normalised photoacoustic signal frequency content for a high red blood cell 
(RBC) concentration (100% of a physiologically normal haematocrit of Ht = 0.41) and a low 
RBC concentration (Ht = 0.01, which corresponds to about 3% of the physiologically normal 
value). The normalised frequency spectra are the means of normalised fast Fourier transforms 
(FFTs) calculated for over 5000 PA signals, and the dotted line shows the normalised 
frequency response of the detector. (b) Weighted mean frequencies (WMFs) calculated from 
the fast Fourier transforms (FFTs) of photoacoustic (PA) signals acquired for different red 
blood cell (RBC) haematocrits. The WMF was calculated by summing the product of the 
amplitudes and the frequencies of the FFT and normalising by the sum of the amplitudes (Eq. 
(3)) . The data points show the mean WMF of over 1500 FFTs calculated for a set of the same 
number of PA signals acquired for each of the relevant RBC concentrations, and the error bars 
represent the standard deviation. The blood samples were taken from human volunteers, 
centrifuged and washed with PBS three times before diluting with PBS to give the range of 
haematocrits shown. In both (a) and (b) the PA signals were generated using 532 nm laser 
pulses and acquired using the 30 MHz focussed transducer positioned at an angle of θ = 45° 
relative to a 390 μm tube containing the blood suspensions. 
The results in Fig. 3 and Fig. 5 have significant implications in terms of transducer selection. 
As stated previously, accurate flow measurement requires that the detected signal retains 
sufficient high frequency content for the blood to be perceived as heterogeneous. The 
beneficial impact of high frequencies is evidenced by Fig. 3 which shows that significantly 
higher accuracy is achieved for the 30 MHz detector compared to the 5 MHz detector; in the 
latter case it is challenging to even detect flow since the RBC suspension is perceived as near-
homogenous at this frequency. However, beyond 30 MHz, the accuracy no longer increases 
significantly and appears to reach a plateau. This is because the high frequency content is now 
limited by spatial averaging due to the lateral FOV of the detector rather than its intrinsic 
bandwidth so increasing the latter does not improve accuracy. The results in Fig. 3 were 
obtained using a low RBC concentration (Ht = 0.023, approximately 5% of a physiologically 
normal haematocrit). For higher concentrations, bandlimiting due to the detector FOV will be 
even more pronounced. As Fig. 5 shows, for a physiologically realistic concentration (Ht = 
0.41), when using the 30 MHz transducer (focal spot diameter = 0.35 mm), the weighted mean 
frequency is less than 20 MHz and thus well below the intrinsic frequency response of the 
detector. Hence, for this concentration, there would be little benefit in increasing the 
transducer bandwidth whilst maintaining the same FOV in the expectation that more of the 
high frequency content conducive to accurate measurements would be retained. These results 
provide useful insight into the factors that govern the detected photoacoustic signal 
0 20 40 60 80
0.0
0.2
0.4
0.6
0.8
1.0
Frequency (MHz)
N
or
m
al
is
ed
 a
m
pl
itu
de
(a)
Ht = 0.41 (100%)
Ht = 0.01 (3%)
Detector response
0.0 0.1 0.2 0.3 0.4 0.5
0
10
20
30
40
50
60
Haematocrit, Ht
W
ei
gh
te
d 
m
ea
n 
fre
qu
en
cy
 (M
H
z)
(b)
#259939 Received 23 Feb 2016; revised 13 May 2016; accepted 15 May 2016; published 23 Jun 2016 
(C) 2016 OSA 1 Jul 2016 | Vol. 7, No. 7 | DOI:10.1364/BOE.7.002789 | BIOMEDICAL OPTICS EXPRESS 2798 
bandwidth. In particular, they explain why the frequency content in whole blood is in the tens 
of MHz range and thus much lower than might otherwise be expected. However, the critical 
question is whether the spatial heterogeneity of whole blood is on a sufficiently large scale to 
permit the detection of motion using acoustic detector frequencies of this order (tens of MHz). 
This is explored in the next section. 
4.2 Absorber heterogeneity: measurements using whole and lysed blood 
 
Fig. 6. The effect of high red blood cell (RBC) concentration and RBC lysis on the accuracy of 
the time correlation velocity measurement. Velocity measurements were made for whole blood 
at a normal physiological haematocrit (grey crosses), a suspension of intact red blood cells 
(12.5% of a normal physiological haematocrit) in phosphate buffered saline (filled data points) 
and for haemolysed red blood cells (also 12.5%) in distilled water (unfilled data points). In 
each case, the fluid was flowing through a 400 µm tube, and the measurements were acquired 
using 540 nm laser pulses separated by T = 0.5 ms and the 30 MHz focussed transducer (θ = 
45°). The length of the range gate was set such that it was greater than the tube diameter so the 
velocity measurement is integrated over the tube cross section. Each data point is the mean of 
three measurements, with a zero offset correction applied, and the vertical error bars represent 
the standard deviation. Microscopy images of the red blood cells are shown on the right. 
The results of the previous section suggest that, for a physiologically realistic RBC 
concentration, the most appropriate transducer amongst those in Table 1 is the 30 MHz 
transducer; bandlimiting due to FOV spatial averaging means there is unlikely to be any 
advantage in using the 50 MHz transducer. 30 MHz is also a reasonable practical upper 
frequency limit in terms of achieving useful penetration depth in tissue. In order to assess 
whether the 30 MHz transducer is able to resolve the heterogeneity of a physiologically 
realistic RBC concentration it was used to detect PA signals in whole blood (RBC 
concentration: 5 x 109 per ml; haematocrit: 0.56; haemoglobin concentration: 155 g/l) flowing 
through a 400 µm tube at various velocities up to 50 mm/s. In these experiments, the length of 
the range gate was set such that it was greater than the tube diameter so the velocity 
measurement is integrated over the tube cross section. The results are shown by the grey 
crosses in Fig. 6 and average to zero for all velocities, suggesting that RBC motion was 
undetectable at this physiologically realistic concentration. This may be explained by the close 
packing of the RBCs; perhaps after all there is insufficient absorber heterogeneity, in other 
words the RBC clustering at this concentration is sufficiently dense that the suspension is 
perceived by the detector as being homogeneous. The experiment was therefore repeated 
under the same conditions but using a lower concentration of RBCs, diluted with phosphate 
buffered saline (PBS) to give a suspension 12.5% of the original haematocrit. In this case, the 
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concentration of the RBCs is sufficiently low that the suspension is perceived as 
heterogeneous and the measurements are in much closer agreement with the known flow 
velocity, as shown by the filled data points in Fig. 6. Finally, in order to destroy the absorber 
heterogeneity, the same concentration (12.5%) was tested again but in distilled water instead 
of PBS: the effect of the water was to haemolyse the cells which causes the haemoglobin to be 
released into the surrounding fluid resulting in an essentially optically homogeneous medium. 
As expected, the unfilled data points in Fig. 6 show that the velocity measurements average to 
zero across the range providing a compelling illustration of the requirement for absorber 
heterogeneity. 
The difference in velocity measurement accuracy between the 12.5% suspension of intact 
RBCs compared to the lysed cell distribution shown in Fig. 6 is readily explained by the 
difference in absorber heterogeneity. However, the different accuracies for the two 
concentrations of intact RBCs (100% and 12.5%) may have an alternative explanation: it is 
possible that the accuracy is affected by the degree of the light penetration [19], and this is 
explored further in the following sub-section. 
4.3 Light penetration 
The measurements for the 12.5% suspension of intact RBCs in Fig. 6 increase linearly and 
show reasonable agreement with the known average flow velocity. However, it is notable that 
there is a consistent under-reading of this average velocity. One possible explanation is that 
the flow velocity profile is parabolic so the RBCs close to the tube wall are moving more 
slowly relative to those at the centre. Preferential absorption of light by the RBCs close to 
tube wall thus leads to a bias in the measurement towards the slower velocities and therefore 
under-reading of the average flow velocity. It is possible that under-reading also occurs for the 
100% suspension for the same reason but to such an extent that the measurements appear to 
be consistently zero – i.e. the reduced optical penetration at this high concentration means the 
signal originates largely from the near static RBCs immediately adjacent to the tube wall thus 
biasing the measurement to zero. Of course, as noted in the previous section, the inability to 
detect flow could equally be a consequence of reduced heterogeneity due to the high 
concentration of the RBC suspension. 
In order to distinguish between the effect of light attenuation from that of absorber 
heterogeneity, the wavelength of the excitation light was varied. By exploiting the spectral 
dependence of haemoglobin absorption, this enables the optical penetration within the tube to 
be varied whilst maintaining constant heterogeneity. Velocity measurements were made with 
blood diluted with PBS to give concentrations of 12.5% and 25%, first using a wavelength of 
540 nm and second using 590 nm where the absorption coefficient of blood is nearly four 
times smaller (see Appendix, Fig. 11). Figure 7(a) shows the velocity measurements at 540 
nm: both concentrations demonstrate under-reading of the average flow velocity, but the 
under-reading is greater for the 25% concentration, which could be explained either by the 
reduced heterogeneity or by the increased light attenuation or a combination of both. As 
shown in Fig. 7(b), at a wavelength of 590 nm, the accuracy of the measurements made with 
both concentrations is excellent with very close agreement to the known velocity. This 
suggests that the greater penetration of light at the longer wavelength yields measurements 
that are less biased towards the slower velocities at the edge of the tube and therefore more 
accurately represent the average flow velocity across the tube. It also suggests that for a 25% 
RBC concentration, there is clearly sufficient absorber heterogeneity and the intrinsic detector 
frequency response characteristics and FOV are not limiting factors in this respect. 
The improvement in accuracy using 590 nm compared to 540 nm is more significant for 
the 25% concentration and so this concentration was used to investigate the effect of different 
wavelengths further. Five velocity measurements were made for the suspension flowing at 15 
mm/s, and at various wavelengths ranging from 460 nm to 650 nm. The results are shown in 
Fig. 8 and compared with the proportion of light penetrating to the centre of the tube, which 
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varies with wavelength according to the absorption spectrum (see Fig. 11). For wavelengths 
between 520 nm and 595 nm there is a clear relationship between the measurement accuracy 
and the light penetration, and it is notable that at most wavelengths there is significant under-
reading of the average flow velocity (accuracy is a fractional error less than 1.0). The best 
accuracies are at the longer wavelengths, particularly at 590 nm and 595 nm, where the light 
penetration is greater than at shorter wavelengths, and therefore the measured velocities more 
closely represent the average flow velocity. For wavelengths beyond 595 nm the measurement 
accuracy deteriorated due to the low SNR, exacerbated not only by the low absorption 
coefficient but also by the reduced laser output at these wavelengths. 
 
Fig. 7. Comparison of velocity measurements made for two different red blood cell 
concentrations, 12.5% and 25% relative to whole blood, and for two different excitation 
wavelengths: 540 nm (a) and 590 nm (b). The length of the range gate was set such that it was 
greater than the tube diameter so the velocity measurement is integrated over the tube cross 
section. At 590 nm, the deeper penetration of light into the tube yields more accurate 
measurements. In each case, the suspensions were flowing in a 400 µm diameter tube, and the 
photoacoustic signals were acquired with a 30 MHz focussed transducer (θ = 45°). The 
measurements were acquired using laser pulses separated by T = 0.5 ms. Each data point is the 
mean of three measurements, with a zero offset correction applied, and the vertical error bars 
represent the standard deviation. 
 
Fig. 8. Variation of measurement accuracy with the wavelength of the excitation lasers. The 
length of the range gate was set such that it was greater than the tube diameter so the velocity 
measurement is integrated over the tube cross section. The solid line represents the percentage 
of light (right axis) that penetrates into the centre of the tube (diameter: 390 µm), calculated 
from the absorption coefficient spectrum of oxyhaemoglobin (see Appendix, Fig. 11). The data 
points correspond to the accuracy (left axis) of velocity measurements made for a blood 
suspension (25% relative to whole blood) flowing at 15 mm/s. For each wavelength, the 
accuracy (1-fractional error) was calculated for the mean of five velocity measurements, and 
the vertical error bars correspond to the standard error. 
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The results in Fig. 7 and Fig. 8 were obtained by setting the length of the range gate such that 
it was greater than the tube diameter so the velocity measurement is integrated over the tube 
cross section. This inevitably gives a weighting to the larger amplitude part of the signal 
arising from the slower moving absorbers near the edge of the tube where most of the light is 
absorbed. This can result in under-reading of the average flow velocity, particularly for the 
more strongly absorbed shorter wavelengths. It has been shown in previous work [19] that 
selection of a range gate corresponding to a deeper region within the tube can remove the bias 
towards lower velocities due to this effect, and thereby improve the measurement accuracy. In 
order to determine the efficacy of this approach for shorter wavelengths where the light 
penetration is limited, it was applied to the photoacoustic signals acquired for the two 
concentrations at 540 nm, and the results are shown in Fig. 9. Comparison with Fig. 7(a) 
shows that this removes the bias towards the slower velocities and thus the measurements 
more accurately correlate with the known average flow velocities. This improvement is 
particularly notable for the 25% concentration where the mean fractional error is initially 
about 37% but is reduced to about 2% after range-gating is applied. 
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Fig. 9. Comparison of the accuracy of velocity measurements made for two different red blood 
cell concentrations, 12.5% and 25% relative to whole blood, and a wavelength of 540 nm. The 
data are those shown in Fig. 7(a) but after time-windowing to remove the bias towards low 
velocities due to the greater absorption at the edge of the tube. 
The results in Fig. 7, Fig. 8 and Fig. 9 highlight two important findings. First, it is clear from 
Fig. 8 that, due to the spectral dependence of the blood absorption coefficient, longer 
wavelengths allow deeper light penetration and therefore the measured velocities more 
accurately match the known average flow velocity; this is also supported by the data in Fig. 7. 
However, Fig. 9 shows that even at a shorter, highly attenuated wavelength of light (540 nm) 
it is still possible to compensate for the bias towards the slower velocities at the edge of the 
tube by analysing time windows of the photoacoustic signal corresponding to a deeper region. 
Second, the ability to achieve accurate measurements using the 12.5% and 25% 
concentrations which are in reasonable proximity to physiologically realistic haematocrits 
suggests that the heterogeneity of whole blood may prove not to be a wholly confounding 
factor. Following these findings, it is therefore now pertinent to consider whether range-gating 
in this way could be employed to improve on the results obtained in Fig. 6 which showed that 
at a physiologically realistic concentration it was not possible to detect flow 
Measurements were therefore made using the “100%” RBC concentration (whole blood at 
a physiologically realistic concentration of 5 x 109 per ml, Ht = 0.56) at two different 
wavelengths, 610 nm and 532 nm, with and without range-gating. The results are plotted in 
Fig. 10. Figure 10(a) shows that without range-gating, even at a long wavelength (610 nm), 
where about 85% of the light penetrates to the centre of the tube, measurement accuracy is 
poor. Despite this, the measurements are not uniformly zero suggesting that it is possible to at 
least detect the motion of the RBC suspension. This implies that the suspension is not being 
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perceived by the detector as wholly homogenous and that the light penetration may still be a 
contributing factor to the poor accuracy. To test this hypothesis, the signals were range-gated 
to select time windows corresponding to deeper regions in the tube and the velocities re-
estimated. These results are displayed in Fig. 10(b) and it can be seen that the accuracy is 
significantly improved particularly below 20 mm/s. 
The measurements at 532 nm further support this interpretation. At this wavelength, where 
only 1% of the light penetrates to the centre of the tube, detection of flow appears impossible 
(Fig. 10(c)) without range-gating. However, when range-gating is applied, the average flow 
velocity can be recovered with reasonable accuracy for speeds less than 20 mm/s, as shown in 
Fig. 10(d). This was achieved by taking many repeated measurements (n = 20), hence the 
larger error bars, whereas for 610 nm fewer measurements were adequate (n = 5). The 
difficulty in making accurate measurements at velocities greater than 20 mms/ is likely to be 
due to de-correlation as the RBCs change their relative positions and move out of the 
transducer focal region, but this could potentially be reduced by using a laser pulse separation 
shorter than the current value of T = 0.5 ms. 
These results illustrate that although limited light penetration compromises measurement 
accuracy, it can be mitigated by appropriate selection of the range gate. Perhaps most notably, 
the results show that measurement can be made in whole blood of a physiologically realistic 
concentration. This suggests that blood is sufficiently heterogeneous to be resolved by 
detectors with a bandwidth of several tens of MHz. 
 
Fig. 10. Velocities measured for fresh, whole blood at a physiologically realistic concentration 
flowing in a tube of diameter 390 μm, and illuminated first with 610 nm light (a,b) and second 
with 532 nm light (c,d). The data were acquired with a laser pulse separation of T = 0.5 ms and 
a 30 MHz focused transducer (θ = 45°). In (a) and (c) the velocities were calculated by cross-
correlating entire photoacoustic waveforms, whereas the velocities in (b) and (d) correspond to 
a single waveform segment selected by time-windowing. In (a) and (b) the data points are the 
mean of 5 velocity measurements and the vertical error bars represent the standard error; in (c) 
and (d) the data points are the mean of 20 velocity measurements and the vertical error bars 
represent the standard error. 
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5. Discussion 
This study has demonstrated that flow measurements can be made using time-correlation AR-
PAF in whole blood at physiologically realistic concentrations. In arriving at this result, new 
insight into the conditions required for accurate measurements has been acquired. This has 
revealed two critical factors that require consideration for the measurement of flow, namely, 
absorber heterogeneity and light penetration. 
As discussed in sections 4.1 and 4.2, the detection and measurement of flow requires the 
RBC suspension to be optically heterogeneous. Figure 6 provides a compelling illustration of 
this requirement, since no motion could be detected after rupturing of the RBCs released 
haemoglobin into the plasma resulting in an optically homogeneous medium. Heterogeneity in 
this context however can only be described relative to the minimum detectable wavelength 
which depends on the detector characteristics. The most obvious consideration is the intrinsic 
transducer frequency response, with lower frequency transducers perceiving reduced 
heterogeneity resulting in reduced velocity measurement accuracy. Less obviously, the signal 
can also be bandlimited and accuracy similarly compromised as a result of the spatial 
averaging effect imposed by the detector FOV. The influence of both characteristics are 
illustrated by the results in Fig. 3 and Fig. 5 respectively, and both confirm previous work 
using absorbing microsphere based flow phantoms [19]. The key implication is that 
heterogeneity cannot be considered in terms of the intrinsic detector centre frequency and 
bandwidth alone; in addition, spatial averaging due to the detector FOV must be considered as 
it can dramatically bandlimit the signal thus reducing the perceived heterogeneity and 
compromising accuracy. 
With the insight provided by the results in Fig. 3 and Fig. 5 we can now begin to consider 
the transducer requirements for successful flow measurements in terms of intrinsic frequency 
response and FOV. Both are inextricably linked. Using a very wide intrinsic detector 
bandwidth extending to several hundred MHz with the intention of resolving the fine 
granularity exhibited by blood would serve little purpose if the signal is bandlimited to a few 
tens of MHz by spatial averaging due to a large detector FOV. This point is illustrated by Fig. 
5(b), which shows that the weighted mean frequency decreases to a plateau around 20 MHz as 
the haemotocrit approaches physiologically realistic levels. In this case, there would be little 
advantage to increasing the transducer frequency (30 MHz) for the same FOV. The question 
then is whether the heterogeneity of blood is on a spatial scale that corresponds to this 
frequency. If it is, then flow measurement should be possible. At first sight, this might seem 
unlikely. If we regard whole blood as a random non-aggregated distribution of individual red 
blood cells at a physiologically realistic concentration of 4 x 109 cells/ml, this would imply a 
mean RBC separation of 2.5 µm which corresponds to a frequency of approximately 600 
MHz. A transducer with a bandwidth of a few tens of MHz as used in this study would 
perceive such a suspension as homogeneous. Indeed, such a transducer would perceive even a 
25% concentration suspension as near homogeneous. However the results in Fig. 7 and Fig. 9 
show that excellent accuracy is possible for this concentration and Fig. 10 shows that flow 
detection is possible even using a 100% RBC suspension. This suggests that blood is 
significantly more heterogeneous than the above model of a random non-aggregated 
distribution of RBC implies. This is perhaps not surprising. It is well known that clustering, 
aggregation and the formation of RBC rouleaux can occur in whole blood. This could result in 
a coarser absorber distribution than might otherwise be expected and one that is sufficiently 
heterogeneous to be resolved by transducers with frequencies in the tens of MHz range as 
used in this study. 
What then are the optimum transducer characteristics? As noted above, flow 
measurements in whole blood at a physiologically realistic concentration were achieved using 
the 30 MHz transducer with 0.35 mm spot size. However, accuracy, resolution and 
repeatability were lower than achieved with the lower concentrations (5%, 12.5% and 25%) 
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suggesting insufficient perceived heterogeneity may still be a negative influence. It may be 
possible to address this by reducing the detector spot size in order to reduce the bandlimiting 
due to spatial averaging. Reducing the spot size however requires reducing T which decreases 
accuracy, resolution and the maximum detectable velocity. A practical lower limit of around 
50 µm is estimated before the technique would be excessively compromised in this respect. 
There may also be benefit in increasing the transducer centre frequency and bandwidth 
although this would incur a cost in tissue penetration depth – for example, acoustic attenuation 
in tissue at 30 MHz for a 5 mm pathlength is approximately 15 dB so increasing the detector 
frequency significantly will reduce penetration depth further, potentially to depths only 
marginally greater than achievable using the optical resolution mode (less than about 1 mm). 
Whilst deeper penetration would be desirable, the results in Fig. 3 suggest that accurate AR-
PAF measurements using detectors sensitive only to a few MHz as required for centimetre 
scale penetration depths may be challenging since blood may be perceived as near 
homogeneous at these frequencies. This does raise the question as to why pulsed Doppler 
ultrasound flowmetry works in vivo using detectors in the low MHz frequency range, even 
though it would seem to have a heterogeneity requirement similar to that of AR-PAF. One 
explanation may be related to the role of speckle. This arises from the presence of sub-
wavelength spatial heterogeneities and is dominant in ultrasound techniques but appears to be 
less so in photoacoustic methods, although the reason for the latter remains incompletely 
understood. 
Whilst limited heterogeneity can compromise measurement accuracy in whole blood, SNR 
may also be a factor. Fundamentally, there is a trade-off between light penetration and SNR. 
Figure 7, Fig. 8 and Fig. 9 show that limited light penetration biases the velocity 
measurements towards under-reading. Measurement accuracy is improved by increasing the 
penetration depth which can be achieved either by employing less attenuated wavelengths of 
light, or by using range-gating to select deeper signal segments. However, by the same token, 
both strategies reduce the SNR. In this study, accurate measurements were possible using 
wavelengths less than 610 nm to irradiate a single blood filled tube immersed in water and 
excited by laser pulses close to the MPE. An in vivo measurement of even a superficial blood 
vessel is likely to result in lower SNR due to higher optical and acoustic attenuation. Although 
such an SNR may still be more than adequate to detect the vessel, it needs to be sufficient to 
resolve the very small fluctuations in the signal on to which the velocity information is 
encoded. In this sense AR-PAF is particularly sensitive to SNR. It remains to be determined 
whether the limiting factor for making accurate, high resolution blood velocity measurements 
is related to heterogeneity or to this critical balance between light penetration and SNR. 
6. Conclusion 
This work has demonstrated for the first time that the velocity of whole blood (100% of a 
physiologically realistic haematocrit) can be estimated using AR-PAF. Moreover it has been 
shown that the spatial heterogeneity of whole blood is sufficient to permit flow detection 
using an ultrasound detector with a centre frequency and bandwidth on a scale of tens of MHz 
and a field-of-view (FOV) of hundreds of micrometres. This somewhat surprising result is 
likely to be due to the aggregated nature of whole blood which results in significantly greater 
spatial heterogeneity than from a non-aggregated random distribution of RBCs thereby 
permitting flow measurement. Measurement accuracy depends on the ability of the transducer 
to resolve the RBC distribution and this depends critically on both the detector frequency and 
the FOV, which in this case were 30 MHz and 350 µm respectively. It is likely that there is 
some further scope to improve accuracy over the results reported in this study via a modest 
increase in transducer frequency and a commensurate reduction in FOV. However a 
significant increase in the transducer frequency would risk excessively reducing penetration 
depth in tissue. Accuracy is also influenced by limited light penetration. Choosing the 
wavelength or applying range-gating in order to increase the depth of the measurement 
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improves accuracy but this inevitably compromises SNR, which in turn can have detrimental 
effects on accuracy and resolution. 
The results obtained in this study are encouraging in that, whilst they confirm that the 
requirement for optical absorption heterogeneity poses a fundamental limit, they also suggest 
that there is sufficient heterogeneity in whole blood to enable in vivo measurements providing 
the transducer characteristics are carefully chosen. Detectors with bandwidths in the tens of 
MHz frequency range can perceive adequate heterogeneity but would probably limit velocity 
measurements to depths of less than 5 mm in tissue. A further limit to the penetration depth is 
imposed by the SNR, which will be reduced when making measurements in vivo and at the 
longer wavelengths required for increased penetration depth. These factors suggest that 
scaling AR-PAF to the upper range of penetration depths (several centimetres) accessible by 
photoacoustic imaging techniques may be challenging and could require additional insight for 
success. Nevertheless, the ability to make blood velocity measurements in the 
microvasculature to even mm scale depths as suggest by the current study would provide a 
valuable complement to existing flowmetry techniques for studying microcirculatory 
abnormalities associated with cancer, diabetes and cardiovascular disease. 
Appendix 
 
Fig. 11. Absorption coefficients for oxyhaemoglobin (solid line) plotted over a wavelength 
range of 450 nm to 680 nm [28]. The data points were obtained by fitting an exponential 
function [29] to photoacoustic waveforms detected in whole blood. There is excellent 
agreement between the measured and literature values for wavelengths below about 590 nm; 
for longer wavelengths the exponential fit becomes less reliable due to the low amplitude 
photoacoustic signal. 
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